| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ef8a1acf91667305ae4176eb2819880 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate |
2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed61b00a0e9e78714f75a1c30f8b5fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc3ece1c34f7d321d153a8db7fde2c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b569db6788c918a4e6736d108c8bcd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d10dfd2ee3ef4ff71558b8940eb53f5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c16715a1387168ec7424ec7c4c741f98 |
| publicationDate |
2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2505204-A2 |
| titleOfInvention |
Method of treating prostate cancer with the GnRH antagonist degarelix |
| abstract |
The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for the treatment of prostate cancer in a subject who is at risk for cardiovascular disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016030334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015308987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821152-B2 |
| priorityDate |
2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |